M&A - ANGIODYNAMICS INC

Form Type: 10-K

Filing Date: 2025-07-18

Corporate Action: Acquisition

Type: New

Accession Number: 000127518725000014

Filing Summary: AngioDynamics, Inc. reported its annual results for the fiscal year ending May 31, 2025, emphasizing its acquisition strategy and restructuring initiatives. The company highlighted its ongoing commitment to enhance capabilities and expand its market presence through strategic acquisitions, particularly in the MedTech segment. Important highlights include management's discussion on financial performance, risk factors, unresolved staff comments, and critical cybersecurity measures. The report also discusses various segments of the business and provides insight into future market risks, expected growth opportunities, and operational plans. The document includes an index outlining business items, risk assessments, management discussions, and financial data necessary for investors and stakeholders.